{"id":"W2902552969","doi":"10.1182/blood-2018-09-876805","title":"Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":378,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Alexion Pharmaceuticals","keywords":"Eculizumab; Medicine; Paroxysmal nocturnal hemoglobinuria; Adverse effect; Hemoglobinuria; Internal medicine; Lactate dehydrogenase; Clinical endpoint; Hemolysis; Gastroenterology; Clinical trial; Immunology; Complement system; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001434848,0.0002597453,0.0003073007,0.0000974774,0.0003211619,0.00003337673,0.0005166864,0.00008909195,0.0007564037],"category_scores_gemma":[0.0001159753,0.0001642081,0.00005892178,0.000278277,0.0003114567,0.0001044679,0.0001981417,0.0001754485,0.0005573812],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004134934,"about_ca_system_score_gemma":0.00007552665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002383773,"about_ca_topic_score_gemma":0.0007203225,"domain_scores_codex":[0.9981335,0.0003801456,0.0004105151,0.0004773538,0.0001254454,0.0004730113],"domain_scores_gemma":[0.9987817,0.0001031038,0.0001552082,0.0007089368,0.0002196999,0.00003133753],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001186799,0.005958363,0.9757356,0.0000168304,0.0003296253,0.00001902258,0.01069342,7.170012e-7,0.00223249,0.0001585748,0.003063431,0.0006051207],"study_design_scores_gemma":[0.03360634,0.0051995,0.9320049,0.0001439008,0.0002183718,0.00002306252,0.01047253,0.000001484501,0.01307393,0.00003503135,0.00468733,0.0005335657],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966202,0.0001796287,0.000005300286,0.0000774172,0.0005606334,0.001430366,0.00003930986,0.00008481697,0.001002303],"genre_scores_gemma":[0.9991548,0.000001159557,0.00001509354,0.0001266942,0.00008888129,0.0002680972,0.00005078172,0.00002439034,0.0002700786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04373065,"threshold_uncertainty_score":0.828209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006469923226486906,"score_gpt":0.2262602937391997,"score_spread":0.2197903705127128,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}